Next Science Limited
NXSCFOTCHealthcare
$0.00
$-0.02(-93.75%)
Market Cap$292625
P/E Ratio—
52W High$0.1133
52W Low$0.0002
Next Science Limited (NXSCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NXSCF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $22.82M | $22.18M | $11.71M | $8.95M | $3.44M |
| Cost of Revenue | $4.37M | $5.94M | $4.99M | $2.70M | $1.37M |
| Gross Profit | $18.44M | $16.23M | $11.90M | $5.94M | $2.47M |
| Gross Margin %(computed) | 80.83% | 73.20% | 101.64% | 66.37% | 71.72% |
| Operating Expenses | |||||
| R&D Expenses | $6.58M | $6.49M | $6.15M | $5.05M | $6.67M |
| G&A Expenses | $6.75M | $5.61M | $5.39M | $4.11M | $3.34M |
| Total Operating Expenses | $28.75M | $32.19M | $30.22M | $15.22M | $16.53M |
| Operating Income | ($10.30M) | ($15.95M) | ($12.70M) | ($9.28M) | ($14.05M) |
| Operating Margin %(computed) | -45.16% | -71.93% | -108.45% | -103.69% | -408.20% |
| Interest Income | $0.11M | $0.42M | $0.01M | $0.02M | $0.11M |
| Interest Expense | $0.28M | $0.74M | $0.03M | $0.02M | $0.02M |
| Income Before Tax | ($10.59M) | ($16.27M) | ($12.68M) | ($9.04M) | ($13.35M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($10.59M) | ($24.51M) | ($18.30M) | ($9.03M) | ($13.35M) |
| Net Margin %(computed) | -46.40% | -110.52% | -156.21% | -100.91% | -388.03% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.04 | $-0.07 | $-0.09 | $-0.05 | $-0.07 |
| Wtd Avg Shares | 291.63M | 234.09M | 210.47M | 196.88M | 187.19M |
| EBITDA | ($9.03M) | ($14.42M) | ($11.78M) | ($9.22M) | ($11.83M) |
| EBITDA Margin %(computed) | -39.57% | -65.02% | -100.54% | -103.04% | -343.79% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Next Science Limited data
About Next Science Limited (NXSCF) Income Statement
Next Science Limited (NXSCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, NXSCF reported revenue of $0.02B, gross profit of $0.02B (gross margin 80.83%), and net income of ($0.01B) — a net profit margin of -46.40%.
Frequently asked questions
NXSCF · 4 questionsNext Science Limited (NXSCF) reported revenue of $0.02B for 2024, up 2.9% year-over-year.
NXSCF revenueNXSCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09